Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 144,207 | 188,411 | 130,524 | 151,890 | 159,767 |
| Cost of Goods | 2,191 | 2,537 | 1,343 | 3,686 | 1,515 |
| Gross Profit | 142,016 | 185,874 | 129,181 | 148,204 | 158,252 |
| Operating Expenses | 285,472 | 276,606 | 243,672 | 356,909 | 217,921 |
| Operating Income | -143,265 | -90,195 | -114,148 | -208,019 | -59,154 |
| Interest Expense | 21,982 | 19,946 | 17,123 | 1,731 | 2,139 |
| Other Income | 24,439 | 32,693 | 18,328 | 165,420 | 14,584 |
| Pre-tax Income | -140,808 | -77,448 | -112,943 | -44,330 | -46,709 |
| Income Tax | 6,602 | 7,842 | 11,380 | 8,100 | 283 |
| Net Income Continuous | -147,410 | -85,290 | -124,323 | -52,430 | -46,992 |
| Net Income | $-147,410 | $-85,290 | $-124,323 | $-52,430 | $-46,992 |
| EPS Basic Total Ops | -1.03 | -0.60 | -0.87 | -0.37 | -0.33 |
| EPS Basic Continuous Ops | -1.03 | -0.60 | -0.87 | -0.37 | -0.33 |
| EPS Diluted Total Ops | -1.03 | -0.60 | -0.87 | -0.37 | -0.33 |
| EPS Diluted Continuous Ops | -1.03 | -0.60 | -0.87 | -0.37 | -0.33 |
| EBITDA(a) | $-143,889 | $-90,465 | $-112,098 | $-201,335 | $-51,507 |